Go to Top



Call for Applications: 2017 – 2018 CanVECTOR Thrombosis Canada Fellowship

         Thrombosis Canada and CanVECTOR are pleased to announce that we are now accepting applications for the 2017 - 2018 CanVECTOR/Thrombosis Canada Fellowship for Knowledge Translation/Clinical Outcomes Research.  The purpose of the CanVECTOR Thrombosis Canada Fellowship is to provide financial support for highly qualified, promising new clinician-investigators to allow them to pursue further training in thromboembolism at

Read More

Thrombosis Canada Announces New Executive Director

Thrombosis Canada, the voice of vascular medicine in Canada since 1991, is pleased to announce the hiring of David Airdrie as its new Executive Director, effective December 1, 2016. This is a new chapter for Thrombosis Canada as it grows and evolves to deliver on its mission to further education, knowledge translation and research in the prevention and treatment of

Read More

Idarucizumab Approved by Health Canada as Dabigatran Antidote

Idarucizumab  is now available as an antidote for dabigatran. Please refer to the highlighted clinical guides, clinical tools, and resources below for further information.  Please note, that Thrombosis Canada in partnership with Think Research has developed a Bleed Management patient order set. Clinical Guides Dabigatran New/Novel Oral Anticoagulants (NOACs): Management of Bleeding Clinical Tools We have also updated our Perioperative Anticoagulant

Read More